Glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, presents a dire prognosis even with current standard treatment regimens including surgery, radiation, and the chemotherapy drug temozolomide (TMZ). However, a groundbreaking study published in Volume 16 of
The field of cancer research has witnessed significant strides over the years, yet the journey to finding highly effective treatments remains complex and challenging. A pivotal aspect driving this progress is the contribution of early-career researchers, whose innovative ideas and fresh
As a promising new frontier in cancer treatment, histotripsy represents a significant advancement in non-invasive medical procedures aimed at eliminating tumors. The technique utilizes bubbles generated via precise ultrasound waves to target and destroy specific cancer cells. Notably, histotripsy
The recent results from the pivotal Phase 3 ROSELLA trial mark a significant development in the battle against platinum-resistant ovarian cancer. Corcept Therapeutics announced that the trial successfully demonstrated the efficacy of combining relacorilant with nab-paclitaxel chemotherapy,
The world of personalized cancer treatment has seen groundbreaking advancements with the introduction of combination immunotherapy, particularly in the realm of metastatic gastrointestinal (GI) cancers. Researchers at the National Cancer Institute (NCI) have developed a transformative approach that
Roche has recently entered into a groundbreaking multi-year collaboration with Oxford BioTherapeutics (OBT), valued at over a billion dollars, to spearhead the development of novel antibody-based cancer treatments. This significant partnership focuses on the creation of innovative therapies such as
